GAMMA Investing LLC Buys 507 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG)

GAMMA Investing LLC raised its stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 10.0% in the 4th quarter, Holdings Channel reports. The firm owned 5,597 shares of the medical equipment provider’s stock after acquiring an additional 507 shares during the period. GAMMA Investing LLC’s holdings in Intuitive Surgical were worth $2,921,000 at the end of the most recent reporting period.

A number of other institutional investors have also recently made changes to their positions in ISRG. Mirador Capital Partners LP raised its stake in Intuitive Surgical by 1.4% during the third quarter. Mirador Capital Partners LP now owns 3,526 shares of the medical equipment provider’s stock valued at $1,732,000 after purchasing an additional 50 shares in the last quarter. Exome Asset Management LLC raised its position in shares of Intuitive Surgical by 16.8% during the 3rd quarter. Exome Asset Management LLC now owns 7,427 shares of the medical equipment provider’s stock valued at $3,649,000 after buying an additional 1,069 shares in the last quarter. Consolidated Planning Corp lifted its holdings in shares of Intuitive Surgical by 17.4% in the 3rd quarter. Consolidated Planning Corp now owns 8,099 shares of the medical equipment provider’s stock valued at $3,979,000 after acquiring an additional 1,198 shares during the last quarter. Healthcare of Ontario Pension Plan Trust Fund grew its position in Intuitive Surgical by 617.1% in the second quarter. Healthcare of Ontario Pension Plan Trust Fund now owns 89,069 shares of the medical equipment provider’s stock worth $39,622,000 after acquiring an additional 76,649 shares in the last quarter. Finally, Swiss National Bank increased its stake in Intuitive Surgical by 0.3% during the third quarter. Swiss National Bank now owns 1,052,800 shares of the medical equipment provider’s stock worth $517,209,000 after acquiring an additional 3,400 shares during the last quarter. Hedge funds and other institutional investors own 83.64% of the company’s stock.

Wall Street Analysts Forecast Growth

Several equities research analysts have recently issued reports on ISRG shares. Citigroup raised their price objective on Intuitive Surgical from $567.00 to $640.00 and gave the company a “buy” rating in a research note on Wednesday, December 11th. Truist Financial lifted their price objective on shares of Intuitive Surgical from $570.00 to $640.00 and gave the stock a “buy” rating in a research note on Wednesday, December 18th. Mizuho increased their target price on shares of Intuitive Surgical from $440.00 to $500.00 in a research note on Thursday, October 17th. Morgan Stanley raised shares of Intuitive Surgical from an “equal weight” rating to an “overweight” rating and lifted their price target for the stock from $522.00 to $650.00 in a research note on Monday, December 2nd. Finally, JPMorgan Chase & Co. increased their price objective on shares of Intuitive Surgical from $495.00 to $575.00 and gave the stock an “overweight” rating in a research report on Friday, October 11th. One equities research analyst has rated the stock with a sell rating, four have issued a hold rating and fifteen have assigned a buy rating to the stock. According to data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $554.17.

Insider Activity

In related news, SVP Mark Brosius sold 2,128 shares of the firm’s stock in a transaction dated Tuesday, October 22nd. The stock was sold at an average price of $515.00, for a total transaction of $1,095,920.00. Following the sale, the senior vice president now owns 273 shares of the company’s stock, valued at $140,595. This trade represents a 88.63 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, EVP Robert Desantis sold 188 shares of Intuitive Surgical stock in a transaction dated Tuesday, October 29th. The shares were sold at an average price of $506.52, for a total value of $95,225.76. Following the completion of the transaction, the executive vice president now owns 5,506 shares in the company, valued at $2,788,899.12. This trade represents a 3.30 % decrease in their position. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 48,190 shares of company stock worth $25,012,927. Corporate insiders own 0.90% of the company’s stock.

Intuitive Surgical Trading Up 0.4 %

ISRG opened at $524.03 on Friday. The company has a market capitalization of $186.65 billion, a price-to-earnings ratio of 84.25, a PEG ratio of 5.31 and a beta of 1.38. Intuitive Surgical, Inc. has a 12-month low of $320.26 and a 12-month high of $556.23. The business’s fifty day simple moving average is $532.28 and its 200-day simple moving average is $489.92.

Intuitive Surgical (NASDAQ:ISRG) last issued its earnings results on Thursday, October 17th. The medical equipment provider reported $1.56 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.24 by $0.32. Intuitive Surgical had a net margin of 28.51% and a return on equity of 13.41%. The company had revenue of $2.04 billion for the quarter, compared to analysts’ expectations of $2.01 billion. On average, equities research analysts predict that Intuitive Surgical, Inc. will post 5.45 EPS for the current year.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.